Entyvio is an intravenous infusion administered to adults who suffer from moderate to severe ulcerative colitis or Crohn’s disease. Entyvio becomes an option when prior prescriptions were not effectively reducing symptoms and inflammation. Entyvio will work to keep the patient’s condition controlled as well as improve the lining of the large intestine.
An Entyvio infusion lasts about 30 minutes and will be followed by an infusion administered two weeks and six weeks after the initial treatment. After this first cycle, it will be routinely administered every two months.